You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The closing range begins at the captured split on Dec 9, 2025.
Fabian Garcia sold 32,000 Unilever PLC ADRs for $2,119,136.00 on 2026/11/06, at prices of $66.22 and $66.23 on the New York Stock Exchange.
Unilever plans a focused HPC portfolio and a global-strategy, local-execution operating model during 2027, targeting annual underlying sales growth of 4–6%, underlying volume growth of at least 2%, and €1 billion in productivity savings by end 2029.
Trian Fund Management, L.P., associated with director Nelson Peltz, sold Unilever PLC ordinary 3 1/2 pence shares on 2026-10-28, 2026-10-29 and 2026-10-30 in connection with a fund expiration, alongside swap-related transactions.
Unilever PLC reported issued share capital of 2,185,205,247 ordinary shares of 3 1/2p each as at 30 October 2026, with 2,154,329,285 shares carrying voting rights.
Fernando Fernandez sold 93,273 Unilever PLC shares on 2026-10-30 for personal financial planning: 30,158 at £48.901367 and 63,115 at €58.474285. He retained 199,132 shares beneficially, above his 700% salary requirement.
Useful current figures from the complete screener profile.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
UL
this stock
Unilever PLC
|
$142.57B | +1.2% | — | — | 0.3% |
|
PG
PROCTER & GAMBLE Co
|
$393.56B | +18.5% | +3.3% | 25.6 | 1.0% |
|
CL
Colgate Palmolive Co
|
$79.23B | +26.1% | +1.7% | 38.9 | 2.3% |
|
RBGLY
Reckitt Benckiser Group PLC
|
$47.99B | — | — | — | 0.0% |
|
EL
Estee Lauder Companies Inc
|
$40.49B | +6.7% | +5.0% | 110.6 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| UL | +0.3% | +0.1% | +16.0% | +1.5% | +1.2% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | -2.3% | +1.2% | +15.5% | +1.6% | -9.4% |
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
